Quarter Period Statement Of Income

RaQualia Pharma Inc. - Filing #7272582

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Quarter period statement of income
Statement of income
Selling, general and administrative expenses
Remuneration for directors (and other officers)
84,516,000 JPY
64,950,000 JPY
63,819,000 JPY
63,819,000 JPY
Amortization of goodwill
203,436,000 JPY
JPY
Operating profit (loss)
-213,383,000 JPY
322,714,000 JPY
-478,408,000 JPY
-337,366,000 JPY
Non-operating income
Interest income
5,306,000 JPY
5,212,000 JPY
3,414,000 JPY
3,426,000 JPY
Non-operating income
67,673,000 JPY
89,524,000 JPY
77,851,000 JPY
88,257,000 JPY
Non-operating expenses
Interest expenses
42,615,000 JPY
42,328,000 JPY
6,681,000 JPY
6,681,000 JPY
Non-operating expenses
215,802,000 JPY
215,512,000 JPY
44,291,000 JPY
44,291,000 JPY
Ordinary profit (loss)
-361,511,000 JPY
196,726,000 JPY
-444,848,000 JPY
-293,400,000 JPY
Extraordinary income
Extraordinary income
9,379,000 JPY
9,379,000 JPY
JPY
JPY
Extraordinary losses
Extraordinary losses
5,600,000 JPY
5,600,000 JPY
649,000 JPY
649,000 JPY
Profit (loss) before income taxes
-357,732,000 JPY
200,505,000 JPY
-445,497,000 JPY
-294,049,000 JPY
Income taxes - current
119,758,000 JPY
158,988,000 JPY
49,528,000 JPY
93,627,000 JPY
Income taxes - deferred
17,540,000 JPY
-14,686,000 JPY
-64,014,000 JPY
-64,014,000 JPY
Income taxes
137,298,000 JPY
144,301,000 JPY
-14,486,000 JPY
29,612,000 JPY
Profit (loss)
56,203,000 JPY
JPY
-495,031,000 JPY
56,203,000 JPY
56,203,000 JPY
-431,011,000 JPY
-431,011,000 JPY
-323,662,000 JPY
-431,011,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.